[ad_1]
Seven people died in the UK from complications associated with blood clots after receiving the AstraZeneca covid-19 vaccine, but British health officials emphasize that the risks are “very small” and advise the population to get vaccinated.
In a statement sent to France-Presse, the UK Medicines and Health Regulatory Agency (MHRA) says seven people have died of blood clots, in a total of 30 cases identified so far.
On Friday, the MHRA announced that it had identified 30 cases of rare blood clots among the 18.1 million people vaccinated with this formula at the end of March.
The health regulator pointed out that the risks associated with these clots are “very small” and that the population must continue to accept the vaccine when it is offered by health services.
Of the 30 incidents, 22 correspond to cerebral venous thrombosis (CVT) and the remaining eight are related to low platelets.
According to the MHRA, seven of these vaccinated people have died and research is underway to determine the link between the deaths and the AstraZeneca vaccine.
MHRA Director June Raine says in the statement that no similar cases have been reported for the Pfizer / BioNTech vaccine.
“The benefits of the AstraZeneca vaccine in preventing COVID-19 infection and its complications continue to outweigh the risks and the public should continue to receive the vaccine,” Raine said.
In addition to the Astrazeneca vaccine, the UK is also using the Pfizer formula. To date, more than 30 million people have received at least the first of two doses of one of these vaccines.
The appearance of cases of blood clots and deaths of people inoculated with this drug has led most European countries, including Portugal, to suspend the administration of this vaccine for a few days, a situation that was overcome after the EMA guaranteed that it is “safe”. and effective ”.
Even so, some countries, such as Norway, maintain the suspension and others, such as Germany, limit vaccination with this vaccine to those over 60 years of age.
